Future Market Insights
Search Reports

Spirometer Market

Starting at US$ 5000

Buy Now
Companies
Industry Size (2025)
USD 684.3 Mn
Forecast (2035)
USD 1157.9 Mn
CAGR (2025 to 2035)
5.4%

Spirometer Market Size and Share Forecast Outlook 2025 to 2035

The global spirometer market is projected to increase from USD 684.3 million in 2025 to USD 1,157.9 million by 2035, registering a CAGR of 5.4%. Growth is being driven by the escalating global burden of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis. According to the World Health Organization, over 300 million people are currently living with asthma worldwide, while COPD accounts for over 3.2 million deaths annually, ranking it among the top three causes of global mortality as of 2025.

Technological innovations have continued to enhance the utility of spirometry devices across clinical and outpatient settings. Medical International Research (MIR) has confirmed that its Spirobank II Smart spirometer is equipped with Bluetooth Low Energy (BLE) and integrates with mobile applications to streamline respiratory data collection. These capabilities have been adopted to support real-time transmission of lung function data in telemedicine programs and mobile diagnostics across North America and Europe.

Spirometry is being increasingly incorporated into occupational health programs and post-COVID-19 pulmonary assessments. With growing awareness around early detection of lung abnormalities, healthcare providers have adopted spirometers for routine check-ups, especially in populations with high exposure to pollution and industrial hazards. In India, spirometry programs have been included under non-communicable disease (NCD) screening in tier-2 cities to address rising asthma and COPD cases linked to urban air quality deterioration.

In addition to hardware, software-driven interpretation of lung function results is being adopted. Algorithms capable of identifying forced expiratory volume (FEV1) and peak expiratory flow rate (PEFR) anomalies are being embedded into handheld spirometers to assist frontline physicians in resource-constrained settings. Integration with electronic health records (EHRs) is also improving longitudinal tracking of patient respiratory data.

Market expansion is being supported by the shift toward home-based care. Portable and handheld spirometers have gained acceptance among patients managing chronic lung conditions. Their adoption has been facilitated by increased reimbursement coverage for digital respiratory monitoring under various health programs.

As disease prevalence rises and healthcare systems emphasize preventive screening, spirometry is expected to remain central to respiratory diagnostics. Enhanced connectivity, portability, and diagnostic precision will continue to influence device adoption through 2035.

Metric Value
Industry Size (2025E) USD 684.3 million
Industry Value (2035F) USD 1,157.9 million
CAGR (2025 to 2035) 5.4%

Analyzing Spirometer Market by Top Investment Segments

Handheld devices remain the most widely adopted format for respiratory diagnostics

In 2025, handheld devices accounted for 46% of the global respiratory diagnostic equipment market and are projected to grow at a CAGR of 5.8% through 2035. Portability, ease of use in outpatient settings, and rapid diagnostic turnaround supported their continued deployment across primary care centers and remote clinics.

In both developed and emerging healthcare markets, handheld spirometers and portable pulse oximeters were favored for COPD and asthma monitoring due to reduced infrastructure requirements. By 2025, public health initiatives in regions such as Southeast Asia and Sub-Saharan Africa integrated handheld devices into community screening programs.

Manufacturers emphasized Bluetooth and app-based integration to enable real-time data transfer and improve patient engagement. The demand for handheld formats was also supported by their suitability for decentralized care delivery and chronic disease monitoring at home.

COPD application continues to drive equipment utilization in public and private healthcare setups

Chronic Obstructive Pulmonary Disease (COPD) accounted for 39% of the total application share in 2025 and is forecast to grow at a CAGR of 5.9% from 2025 to 2035. Diagnostic demand was driven by the growing incidence of COPD linked to air pollution, tobacco use, and occupational exposure.

In 2025, screening and monitoring were prioritized across urban populations in India, China, Brazil, and parts of Eastern Europe, where underdiagnosis remained a concern. Public health authorities introduced spirometry-based assessments as part of routine checkups in high-risk groups aged 40 and above.

Private diagnostic chains and pulmonary clinics expanded COPD testing infrastructure by procuring portable and digital diagnostic units. Equipment adoption was further supported by the global shift toward early-stage intervention and disease management aimed at reducing long-term hospitalizations.

Challenges

High Costs of Advanced Spirometry Devices

High costs of advanced spirometers limit the adoption of AI and digital technologies among healthcare providers. While AI-driven spirometers provide more accurate lung function evaluation, the complexity of sensors, cloud storage, and wireless connectivity comes at a cost that drives the manufacturing cost higher.

This technology has its own needs, and the costs are passed along to end-users, making it difficult for hospitals and clinics in low- and middle-income countries to make that kind of investment. Consequently, many health care facilities are still using inadequate or less precise spirometry alternatives for such purposes, delaying the diagnosis of respiratory diseases.

This affordability gap also extends to home-based spirometry adoption; as premium portable devices continue to remain too expensive for many patients. Meeting this challenge depends on the development of cost-effective solutions, the subsidization by governments and a flexible financing model to promote access to modern spirometry technology.

Lack of Awareness and Skilled Professionals

The absence of awareness and trained professionals who can perform and interpret the lung function tests is one of the key factors acting as a barrier to the spirometer market. Thus, spirometry is not part of routine diagnosis performed by healthcare providers in many developing areas of the world, which leads to underdiagnosed and untreated obstructive diseases, COPD, and asthma.

The lack of awareness is particularly common in rural settings with limited healthcare education, leading to a lower engagement of spirometry testing. Moreover, interpretation of spirometry results accurately is dependent on well-trained pulmonologists and respiratory technicians; however, there is a global shortage of trained professionals in this area.

Improperly trained tests can delay critical interventions and worsen patient outcome due to misinterpretation of results. Solutions here include increasing awareness campaigns, adding spirometry courses into the medical curriculum, and implementing AI-based solutions in assisting and determining the interpretation of results.

Opportunities

Rising Adoption of Telemedicine & Remote Monitoring

The increasing adoption of telemedicine systems in health care is a promising pow for spirometry, especially in chronic disease management. Through telehealth platforms, patients can track lung health at home using Bluetooth-enabled portable spirometers that send live readings to the doctor.

This limitation would minimize the need for repeated visits to the hospital especially for patients with asthma as well as COPD who require a constant assessment. Remote spirometry improves patient adherence and ability to monitor lung function from home. It also enables proactive disease progression detection, leading to early medical treatment. Spirometry offers healthcare solutions in areas with limited access to pulmonologists.

With governments and insurers offering greater support for telehealth initiatives, the demand for connected spirometry solutions is projected to increase, driving this market's growth and fostering respiratory health outcomes worldwide.

Technological Advancements in AI and Cloud-Based Spirometry

AI to evaluate respiratory patterns, identify anomalies, and offer real-time analytical insights, minimizing the need for specialist interpretations. Smart algorithms increase diagnostic accuracy and inter operator reliability, making diagnoses for conditions such as asthma and COPD more reliable.

Also, cloud-based storage makes it easy to access data anywhere and share it instantly between patients and practitioners enhancing remote diagnosis capabilities. AI has also led to the use of predictive models to pinpoint early markers of the disease and refine preventive care strategies.

AI also streamlines the testing process in spirometry, allowing more non-specialized teams to conduct and interpret tests. The rapid adoption of digital health will further catalyze these innovations and drive spirometry adoption in primary care and home-based health settings, improving the accessibility and availability of respiratory diagnostics.

Country-wise Analysis

United States

The growing prevalence of respiratory diseases, increasing healthcare expenditure and the adoption of advanced diagnostic tools are driving the growth of the spirometer market in US. By raising awareness of lung health and the potential for early disease detection, this trend is expected to fuel demand even more.

Moreover, the increased use of telemedicine and home-based spirometry solutions is changing the face of pulmonary care. The market trends are influenced by government initiatives like funding for chronic disease management and strict regulatory standards. Leading healthcare companies and investments in AI-driven spirometry solutions are anticipated to play an important role in driving growth during the forecast period.

  • Rising Prevalence of COPD & Asthma: High demand for precise respiratory diagnostics.
  • Growth in Telemedicine & Remote Monitoring: Adoption of home-use spirometers.
  • Technological Advancements in Pulmonary Testing: Integration of AI-driven diagnostics.
  • Government & Insurance Support for Chronic Disease Management: Expansion of lung health programs.
  • Increasing Healthcare Expenditures & Investments: Expansion of pulmonary care in hospitals and clinics.
Country CAGR (2025 to 2035)
United States 5.6%

United Kingdom

The increasing emphasis on early detection of respiratory ailments and government initiatives to endorse lung health are propelling the growth of the spirometer market in the UK. There has been an increase in spirometry tests as management programs for COPD and asthma are supported by the National Health Service (NHS).

Moreover, the trend toward portable and digital spirometers is improving diagnostic accessibility. Other potential areas of growth in the respiratory diagnostics market include the introduction of artificial intelligence (AI) and machine learning (ML) into the field.

  • Government-Supported Respiratory Screening Programs: NHS initiatives for early disease detection.
  • Growth in Home-Based & Portable Spirometers: Growing need for personal monitoring of respiratory conditions.
  • Advancements in AI-Powered Diagnostics: Adoption of intelligent lung function analysis.
  • Rising Cases of Respiratory Disorders: Increased call for spirometry testing in clinical settings.
  • Expansion in Digital Health & Remote Monitoring: Enhancements in connected health solutions.
Country CAGR (2025 to 2035)
United Kingdom 5.3%

European Union

The growth of the European Union (EU) spirometer market can be attributed to the expanding investments in healthcare infrastructure, rising cases of respiratory conditions, and strong government support for chronic disease management in the region.

Major governing bodies like European Respiratory Society (ERS) have already indicated the importance of early detection and continuous monitoring of lung disease. Moreover, the solid focus of the region in integrating digital health and this is leading to the adoption of smart spirometry devices.

  • Government-Funded Lung Health Programs: Initiatives to improve respiratory disease management.
  • Growth in AI-Integrated Diagnostic Tools: Increased adoption of intelligent spirometry devices.
  • Advancements in Wireless & Portable Spirometry: Growth in home-use and telemedicine applications.
  • Strong Regulatory Framework Supporting Early Diagnosis: Fulfilment of EU health policies.
  • Increasing Healthcare Investments in Pulmonary Care: Growth in number of pulmonary clinics and specialized treatment centers.
Region CAGR (2025 to 2035)
European Union 5.5%

Japan

Japan spirometer market is being driven by aging population, high prevalence of respiratory diseases and technological advancement in medical technology in the country. Emergence of the government initiatives towards preventive healthcare coupled with the emergence of telehealth solutions will propel the home spirometry market in future.

Furthermore, the robust R&D landscape of Japan is contributing to developments of compact and artificial intelligence (AI)-enabled spirometers, offering more accurate and user-friendly devices for respiratory diagnostics.

  • Aging Population & Increased Respiratory Disease Cases: Increasing demand for lung function testing.
  • Advancements in Miniaturized & Smart Spirometers: Development of compact and portable devices.
  • Government Support for Digital Health Solutions: Expansion of telehealth programs.
  • Innovations in AI-Based Pulmonary Function Analysis: Improving diagnostic accuracy and efficiency.
  • High Adoption of Home Healthcare Devices: Rise in personal spirometry for chronic disease monitoring.
Country CAGR (2025 to 2035)
Japan 5.2%

South Korea

South Korea spirometer market is propelling on account of rapid innovation in digital healthcare, increasing prevalence of respiratory disease and government initiatives for better accessibility to healthcare services. Investment in AI-driven diagnostics and telemedicine in the country is helping in the adoption of smart spirometry solutions.

Moreover, growing environmental pollution and occupational lung diseases are boosting the necessity of periodic lung function tests. Technological advancements such as introduction of wearable and wireless spirometers will further facilitate the growth of market.

  • Rise in Digital & AI-Based Healthcare Solutions: Adoption of smart diagnostics is rising.
  • Government Support for Respiratory Disease Management: Government policies supporting management of respiratory disease, including early screening.
  • Expansion in Portable & Wearable Spirometers: Increasing demand for portable spirometers for lung health monitoring.
  • Increasing Awareness of Air Pollution & Lung Health: Demand for regular pulmonary testing is increasing.
  • Investment in Smart & Connected Medical Devices: Growth in IoT-enabled respiratory monitoring systems.
Country CAGR (2025 to 2035)
South Korea 5.4%

Competitive Outlook

The global spirometer market is witnessing steady growth supported by the growing burden of chronic respiratory diseases (CRDs) such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and post-COVID lung ailments. Increase in air pollution, smoking trends, and occupational lung diseases is expected to augment demand for spirometers in the hospitals, clinics, and home-based care.

New technologies such as Bluetooth-enabled spirometers, machine-learning algorithms detecting lung function based on imagery, and cloud-based data storage are improving diagnostics and making them more scalable. Moreover, the market is also driven by government initiatives, and healthcare policies that promote early detection of respiratory diseases.

The adoption of portable and home-use spirometers has been gaining traction with the rise of remote patient monitoring (RPM) / telehealth fusion. Product innovation, regulatory compliance and global market penetration are key strategies employed by the market players to stay competitive.

Key Company Insights

Hill-Rom Holdings, Inc.

Hill-Rom Holdings with Welch Allyn is a leading supplier for hospital-grade spirometry solutions. The company is also emphasizing seamless integration with electronic health records (EHRs) to make data easily available for healthcare providers.

Hill-Rom is also placing its money on AI-driven analysis of lung function and automated calibration, both used to improve diagnostic efficiency. The company is expanding telehealth-enabled peripheral devices for remote respiratory monitoring backed by a strong presence in North America, Europe and Asia.

Schiller AG

Schiller AG is known for its high-precision spirometry systems, which are extensively used in hospitals and clinics as well as research institutions. Innovating PC-based and touchscreen spirometers: Easy to use, digital data storage. Schiller's spirometers are integrated with ECG and pulmonary function testing (PFT) systems, similar ideal diagnostic solution. Its focus on precision medicine and clinical-grade respiratory diagnostics had seen strong reception in Europe, North America, and emerging markets.

MIR - Medical International Research

MIR is a leading manufacturer of portable and handheld spirometers for the home-care and telemedicine markets. The business focuses on wireless and Bluetooth-enabled devices that sync with mobile apps for real-time lung function monitoring. MIR's telehealth and wearable spirometry solutions have a solid track record in Europe, Asia and North America, and the company is looking to expand its reach even further.

Vitalograph Ltd

Vitalograph is a leading brand in diagnostic spirometry for clinical research, occupational health and telemedicine. The firm is also working on AI-based lung function analysis and cloud-powered spirometry for distant patient monitoring. Focused on Europe, North America and emerging markets, Vitalograph plans to further expand its hospital and home-based spirometry portfolio.

NDD Medical Technologies

NDD Medical Technologies' line of ultrasonic-based spirometers that require no traditional calibration. The company's expertise lies in high-precision lung function testing, targeting the hospital, clinical research and pharmaceutical sectors. NDD which serves North America, Europe, and Asia - is branching into point-of-care and home-use spirometry devices.

Key Players

  • MGC Diagnostics
  • NDD Medical Technologies
  • KoKo PFT
  • ICU Medical
  • Koninklijke Philips N.V.
  • Jones Medical Instrument Company
  • Medical International Research
  • COSMED
  • Schiller AG
  • Vitalograph

Market Segmentation

Key Segments of Spirometer Market

By Product Type:

In terms of product type, the industry is divided into Device (Handheld, Desktop, Table-top), Consumables And Accessories, Software.

By Application:

In terms of Application, the industry is divided into Copd, Asthma, Cystic Fibrosis, Pulmonary Fibrosis

By Region:

The report covers key regions, including North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia, and the Middle East and Africa (MEA).

Frequently Asked Questions

What is the estimated market size of the global Spirometer market for 2025?

The global Spirometer market is projected to reach USD 684.3 million by the end of 2025.

At what rate is the market expected to grow during the forecast period?

The market is anticipated to grow at a CAGR of 5.4% over the forecast period.

What is the projected market worth by 2035?

By 2035, the Spirometer market is expected to reach USD 1,157.9 million.

Which segment is expected to dominate the market?

The diagnostic spirometers segment is expected to dominate the market, driven by increasing demand for lung function assessment in respiratory diseases such as COPD and asthma.

Who are the key players in the Spirometer market?

Key players in the Spirometer market include Hillrom (a subsidiary of Baxter), Vyaire Medical, Schiller AG, Vitalograph, and MIR Medical International Research.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Spirometer Market